Global investors are increasingly examining alternative indicators to evaluate future corporate consolidation trends. Data from prediction market platform Polymarket provides insight into which companies market participants believe could become acquisition targets before 2027, offering a forward-looking perspective on potential mergers and acquisitions across multiple sectors.

The market—tracking more than $16.7 million in trading volume and running until December 31, 2026—includes companies spanning biotechnology, artificial intelligence, consumer brands, and software platforms. While prediction markets reflect investor sentiment rather than confirmed transactions, they can highlight industries where consolidation pressures are intensifying.

Biotechnology Firms Lead Acquisition Expectations

Among the companies tracked, Viking Therapeutics stands out with the highest probability of acquisition at 61%. The biotechnology company, which focuses on treatments for metabolic and endocrine disorders, has attracted strong investor attention as large pharmaceutical companies continue searching for innovative therapies to strengthen their development pipelines.

The biotechnology sector has historically been one of the most active areas for corporate acquisitions. Major pharmaceutical companies often acquire smaller firms once promising clinical trial results emerge, allowing them to accelerate drug development while addressing upcoming patent expirations. The high probability assigned to Viking Therapeutics reflects expectations that companies developing therapies targeting obesity, diabetes, and metabolic diseases may become attractive assets for global pharmaceutical groups.

Technology Platforms and AI Startups Draw Acquisition Interest

The technology sector also features prominently in acquisition expectations. GitLab, the developer operations platform widely used for software collaboration and DevOps infrastructure, carries an estimated 43% probability of acquisition with trading volume exceeding $1.1 million. As digital transformation accelerates globally, developer platforms and cloud-based software ecosystems have become increasingly valuable to large technology companies.

Artificial intelligence firms are also gaining attention as potential acquisition targets. Perplexity AI holds a 28% probability of acquisition, while Anthropic stands at 13%. These figures reflect the intensifying competition among technology companies seeking to secure advanced AI capabilities in areas such as generative AI, AI-powered search, and enterprise automation.

Other companies appearing in the market include OpenAI (10%), Snapchat (10%), and Zoom Video Communications (9%), though lower probabilities suggest investors currently see fewer near-term catalysts for potential acquisition scenarios.

Consumer Brands and Gaming Companies Enter the M&A Discussion

Beyond technology and biotechnology, prediction market data suggests potential consolidation in consumer and entertainment sectors. Pizza Hut carries a 47% probability of acquisition, while gaming publisher Ubisoft shows a 36% probability. Both industries have experienced structural changes that may encourage consolidation as companies pursue scale, intellectual property expansion, and global distribution advantages.

The gaming industry in particular has experienced a wave of consolidation in recent years as publishers attempt to strengthen development capabilities and intellectual property portfolios. Ubisoft, known for globally recognized gaming franchises, has periodically been the subject of acquisition speculation within the sector.

Additional companies tracked in the prediction market include Nebius Group (25%), Lovable (27%), and energy company BP (28%), illustrating how acquisition speculation spans multiple sectors of the global economy.

Looking ahead, prediction markets provide a unique perspective on investor expectations regarding corporate consolidation trends. While probabilities can shift rapidly as industry conditions evolve, the data suggests that mergers and acquisitions could remain a defining feature of global markets through the second half of the decade. Investors will likely continue monitoring developments in biotechnology innovation, artificial intelligence competition, and industry restructuring that could trigger the next wave of major corporate transactions.